Display options
Share it on

J Med Case Rep. 2014 Apr 02;8:110. doi: 10.1186/1752-1947-8-110.

Anaphylactic reaction to intravenous corticosteroids in the treatment of ocular toxoplasmosis: a case report.

Journal of medical case reports

Achim Fieß, Sven Halstenberg, Antonia Fellas, Inez Frisch, Ulrich Helmut Steinhorst

Affiliations

  1. Department of Ophthalmology, Dr, Horst-Schmidt-Clinics, Wiesbaden, Germany. [email protected].

PMID: 24694257 PMCID: PMC4230808 DOI: 10.1186/1752-1947-8-110

Abstract

INTRODUCTION: This case report presents for the first time an acute systemic allergic reaction to corticosteroids in a patient with ocular toxoplasmosis after treatment with intravenous cortisone, and discusses alternative treatments.

CASE PRESENTATION: We present the case of a 57-year-old Caucasian woman with an anaphylactic reaction after intravenous injection of prednisolone-21-hydrogensuccinate (Solu-Decortin® H) given for the treatment of toxoplasmosis-associated chorioretinitis. Immediately after the injection, she developed an acute erythema of the legs and abdomen, angioedema, hypotension (blood pressure 80/40mmHg), tachycardia (heart rate 140/minute), hyperthermia (38.8°C), and respiratory distress. Allergological examinations showed a positive skin-prick test to prednisolone and methylprednisolone. In addition, an oral exposure test with dexamethasone (Fortecortin®) and betamethasone (Celestamine®) was conducted to find alternative corticosteroids for future treatments. After oral application, no local or systemic reactions were observed for these two substances.

CONCLUSIONS: This case report demonstrates that systemic allergic reactions are possible in patients with uveitis or other inflammatory ophthalmological conditions treated with intravenous corticosteroids. Intravenous administration of cortisone, for example, in the treatment of ocular toxoplasmosis, should always be conducted with caution because of a possible allergic reaction. For patients who react to a particular steroid, it is necessary to undergo allergological testing to confirm that the compound in question is indeed allergenic, and to identify other corticosteroids that are safe for future anti-inflammatory treatments.

References

  1. Transplantation. 1983 Nov;36(5):594-6 - PubMed
  2. Br J Dermatol. 1993 Apr;128(4):407-11 - PubMed
  3. Contact Dermatitis. 1992 Mar;26(3):182-91 - PubMed
  4. Hautarzt. 1959 Jan;10:42-3 - PubMed
  5. Arch Dermatol. 1995 Jun;131(6):742-3 - PubMed
  6. Neurology. 1984 Aug;34(8):1119-21 - PubMed
  7. Srp Arh Celok Lek. 2012 Mar-Apr;140(3-4):233-5 - PubMed
  8. Allergy. 2001 Apr;56(4):352-3 - PubMed
  9. Proc Staff Meet Mayo Clin. 1949 Apr 13;24(8):181-97 - PubMed
  10. Lancet. 2004 Jun 12;363(9425):1965-76 - PubMed
  11. Ann Allergy Asthma Immunol. 2002 Oct;89(4):425-8 - PubMed
  12. Derm Beruf Umwelt. 1990 May-Jun;38(3):75-90 - PubMed
  13. Ophthalmology. 2011 Jan;118(1):134-41 - PubMed
  14. Clin Allergy. 1983 Sep;13(5):499-500 - PubMed
  15. Am J Ophthalmol. 2003 Dec;136(6):973-88 - PubMed
  16. Ann Intern Med. 1988 Mar;108(3):487-8 - PubMed
  17. Eur J Ophthalmol. 2009 Nov-Dec;19(6):1039-43 - PubMed
  18. J Allergy Clin Immunol. 1974 Sep;54(3):125-31 - PubMed
  19. Laryngorhinootologie. 1999 Oct;78(10):573-8 - PubMed

Publication Types